MedRhythms Inc., based in Portland, US, develops music-based digital therapeutics that improve mobility for neurological patients.
Founded in 2013 and based in Portland, US, MedRhythms Inc. develops digital therapeutics that use music and technology to improve mobility in people with neurological conditions. Its flagship product, InTandem, is available by prescription and uses Rhythmic Auditory Stimulation, a patented technology that combines sensors, software and curated music. Its Series B round on April 29, 2025 raised USD 19.781 mn, and CEI Ventures Management provided venture funding in April 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in